#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrodysplasia ossificans progressiva Fallopian tube cancer Scleroderma associated digital ulcer Metastatic gastric cancer Ataxia telangiectasia Anaemia Basal cell naevus syndrome Polymyositis Autoimmune disorder Immunodeficiency Osteochondrodysplasia Ependymoma Alexander disease Ovarian epithelial cancer Obesity More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Treatment Stevens-Johnson syndrome – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Marginal zone lymphoma refractory – Diagnostics Indolent systemic mastocytosis – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Inclusion body myositis – Treatment Mantle cell lymphoma stage IV – Diagnostics Ornithine transcarbamoylase deficiency – Treatment Activated PI3 kinase delta syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rosuvastatin Ep262 Oxazepam Chloropyramine Hydrochloride Oregovomab Eplontersen Skb264 Idelalisib Zagociguat Aldesleukin Art0380 Mesilate ZINC Wt1 Lamp Mrna Dc Davutamig Cimetidine Hydrochloride Moxifloxacin Hydrochloride Rbd1016 Sulfasalazine Tolebrutinib Ozanimod More therapies…

    Learn about Your Condition

    Persistent depressive disorder Medication overuse headache Pneumococcal infection Primary myelofibrosis Diabetes insipidus Pterygium Inclusion body myositis Mucopolysaccharidosis Epicondylitis Pharyngeal cancer stage II Thrombolysis Aphthous ulcer Anal cancer recurrent Bacterial infection Muscular dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Evaluating Safety and Effectiveness of Combining Biologic Medications for Patients with Rheumatoid Arthritis and Psoriatic Arthritis ## Human: Give a detailed summary of a clinical trial for patients: 1.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tocilizumab
    Spain

  • Evaluation of Datopotamab Deruxtecan in Patients with Non-Squamous Non-Small Cell Lung Cancer and Active Brain Metastases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Dexchlorpheniramine Maleate
    • Datopotamab Deruxtecan
    • Diphenhydramine Hydrochloride
    Austria Spain

  • Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    France Germany Hungary Italy Spain

  • Evaluating Technetium-99m and Cyanine-5 PSMA Tracer-Guided Surgery for Patients with Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 99MTC-EUK-(SO3)CY5-MAS3
    The Netherlands

  • Safety and Effectiveness of Intravenous Sonazoid for Contrast-Enhanced Liver Ultrasound in Children with Focal Liver Lesions

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Perflubutane
    Germany Italy

  • Study on Fecal Microbiota Transplantation and Amoxicillin-Clavulanic Acid for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Allogeneic Faecal Microbiota
    France
Previous Page
1 … 782 783 784 785 786 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!